Computational Screening of Columbianadin-Derived Furanocoumarins as Multitarget Neurotherapeutics Against MAO-B, AChE, and BACE1 For Alzheimer's Disease
Background: Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by multiple pathological pathways, including monoamine oxidase activity, cholinergic dysfunction, and amyloid-β peptide accumulation. Developing multi-targeted neurotherapeutics has emerged as a promising approach to address this...